Thursday, August 9, 2012 5:21 PM
|
CCSVI in Multiple Sclerosis
Thanks to Christopher--ANOTHER RADIO INTERVIEW WITH DR. DANIELLE ROBITAILLE, Montreal Hematologist following CCSVI patients She discusses: 1. The safety of angioplasty. 2. The importance of follow-up care. 3. Why the improvements can not be considered a placebo effect. French audio with English subtitles ROBITAILLE RADIO INTERVIEW AUGUST 2ND, 2012 SUBTITLEDSubtitled radio interview with Montreal Hematologist, Dr. Danielle Robitaille. She discusses points like: Why the Sherbrooke Study is faulty, The improvement...
|